Navigation Links
Study Hints at Link Between Antidepressants and Heart Trouble

By Steven Reinberg
HealthDay Reporter

SATURDAY, April 2 (HealthDay News) -- Men taking antidepressants may be at risk for atherosclerosis, which can increase the risk of a heart attack or stroke, a small, preliminary study suggests.

Antidepressants were associated with about a 5 percent increase in the thickness of the large artery in the neck called the carotid artery, which carries blood to the brain, the researchers from Emory University found.

Yet experts not involved with the study noted that it did not prove a cause-and-effect relationship between antidepressant use and heart trouble, and added that depression itself can increase the risk of cardiovascular problems.

"Antidepressant medications may decrease cardiovascular risk by treating depression," said Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles.

Since the new findings are very preliminary, Fonarow said, "Patients should not be concerned or stop taking antidepressant medications on the basis of this study."

Results of the research were scheduled to be presented Saturday at the American College of Cardiology's annual scientific session, in New Orleans. Experts note that studies presented at medical conferences do not undergo the same vetting as research published in peer-reviewed journals. The study was funded by the U.S. National Institutes of Health.

For the study, a team led by Dr. Amit Shah, a cardiology fellow at Emory, collected data on 513 middle-aged male twins who were part of the Vietnam Era Twin Registry. Sixteen percent of the men were taking antidepressants, and of these, 60 percent were taking selective serotonin reuptake inhibitors (SSRIs), such as Prozac, Lexapro and Zoloft. The others were taking older antidepressants.

To try to isolate the effect of antidepressants on blood vessels, the researchers measured the thickness of the carotid artery -- called carotid intima-media thickness. The study authors found that a twin taking an antidepressant had a greater intima-media thickness than a brother not taking the drugs.

The finding held true, regardless of the antidepressant taken, the researchers said.

"There is a clear association between increased intima-media thickness and taking an antidepressant, and this trend is even stronger when we look at people who are on these medications and are more depressed," Shah said in a news release from the American College of Cardiology.

"Because we didn't see an association between depression itself and a thickening of the carotid artery, it strengthens the argument that it is more likely the antidepressants than the actual depression that could be behind the association," he added.

The findings also held true after compensating for such factors as age, diabetes, blood pressure, current or previous smoking, cholesterol and weight. Other factors weighed included depressive symptoms, history of major depression and heart disease, alcohol and coffee use, statin use, physical activity, education and employment, the researchers said.

Since each additional year of life is associated with a small increase in intima-media thickness, a brother taking antidepressants is physically 4 years older than the brother not taking antidepressants, Shah's team contended. They also said that even a small increase in intima-media thickness can increase the risk of a heart attack or stroke by 1.8 percent.

It's not clear why there might be an association between antidepressant use and heart disease, the study authors noted. These drugs increase levels of the brain chemicals serotonin and norepinephrine, which are often low in depressed individuals.

Shah said increased levels of these chemicals may cause blood vessels to tighten, and this may lead to reduced blood flow to organs and higher blood pressure, which is a risk factor for atherosclerosis.

Commenting on the study, Dr. Dominique L. Musselman, an associate professor of clinical psychiatry at the University of Miami Miller School of Medicine, underscored that the findings show an association between antidepressant use and atherosclerosis, but not a cause-and-effect relationship.

"This finding is somewhat counterintuitive since it is well known that SSRIs enhance a tendency to bleed," she said, adding that more rigorous studies are needed to see if a cause-and-effect relationship exists.

Musselman also strongly advises patients not to stop taking antidepressants based on this study. Not treating depression can have serious consequences for quality of life, survival after a heart attack or other cardiovascular events, she said.

"This is an important finding that needs to be replicated," she added.

More information

For more on antidepressants, visit the U.S. National Library of Medicine.

SOURCES: Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Dominique L. Musselman, M.D., associate professor of clinical psychiatry, University of Miami Miller School of Medicine; April 2, 2011, presentation, American College of Cardiology annual scientific session, New Orleans

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: